The FDA has approved Degevma (denosumab-adet), a new biosimilar to Xgeva, to prevent skeletal-related events in patients with bone metastases.
PACE is the first phase 3 randomized trial directly comparing radical prostatectomy with SBRT in men with low- to intermediate-risk prostate cancer.
Trial investigators evaluated the prognostic and predictive ability of PAM50 molecular prostate cancer subtypes to guide salvage treatment.
Genetic testing was performed in patients with FSGS, classic MCD, and MCD with IgM deposition, with no pathogenic or likely pathogenic variants associated with monogenic SRNS identified. In children ...
Men with frailty have higher risk for cognitive impairment than men without frailty, but no association seen in women.
The effects of semaglutide on major adverse cardiovascular events (MACE) is only partially due to known risk factors, according to a study published online Sept. 23 in the European Heart Journal.
Elevated C-Reactive Protein Linked to Increased Risk for Incident Heart Failure, All-Cause Mortality
Findings seen in adults aged 40 to 80 years with at least two cardiovascular risk factors. (HealthDay News) — For adults with an increased cardiovascular risk, elevated C-reactive protein (CRP) levels ...
Dr Rena Malik is a board-certified urologist, pelvic surgeon, and sexual health expert whose social media channels educate millions of subscribers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results